Skip to main content
. 2016 Apr 12;11(4):e0152895. doi: 10.1371/journal.pone.0152895

Table 4. Average percent change of mRNAs at end treatment relative to pre-treatment.

mRNA BSH Dose
50g 100g 150g
hmox1 +65.5% +41.8% +53.5%*
nqo1 +44.2% +14.4% -0.7%
hbg1 +65.2% +130.8%* +21.6%
hbg1/(hbb+hbg1) -1.4% +2.6% +10.7%

*significant difference between pre-treatment and end treatment (p <0.05)